Evidence map›Paper›PMID 27242721›Full record

ReviewFrontiers in microbiology2016

How to Optimize the Use of Blood Cultures for the Diagnosis of Bloodstream Infections? A State-of-the Art.

Brigitte Lamy, Sylvie Dargère, Maiken C Arendrup, Jean-Jacques Parienti, Pierre Tattevin

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 225 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
225citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03089697 phase2terminatednot on this mapstarted 2017, after this paper: background citation

A Randomized, Double-blind, Placebo-controlled, Multicenter Phase IIa Clinical Study to Evaluate Safety and to Explore Efficacy of N-Rephasin® SAL200, in Patients With Persistent Staphylococcus Aureus Bacteremia

TypeinterventionalSponsorIntron Biotechnology, Inc.Ran2017 to 2019Enrolled25ConditionsStaphylococcus Aureus Bacteremia, Anti-Bacterial AgentsArmsN-Rephasin® SAL200, Placebo
NCT05686577 completednot on this mapstarted 2022, after this paper: background citation

Comment Diminuer Les hémocultures Inutiles : Construction et Validation d'un Score prédictif de positivité Des hémocultures en réanimation.

TypeobservationalSponsorUniversity Hospital, ToursRan2022 to 2023Enrolled2,411ConditionsInfection, Bacterial, Infection, Fungal, BacteremiaArmsno intervention
3 · Its place in the literature

Who cites it

225 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Impact on blood cultures pre-analytical quality and positivity rate of a key performance indicators digital monitoring approach: a pre-post intervention study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  5. ESBL-ProducingPathogens (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Hour-1 Sepsis Bundle: Updated Evidence.Journal of clinical medicine · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. In-depth analysis of sampling practice and yield of blood cultures.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article

165 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Brigitte LamyLaboratoire de Bactériologie, CHU Montpellier Montpellier, France.
Sylvie DargèreService de Maladies Infectieuses, CHU Caen Caen, France.
Maiken C ArendrupUnit for Mycology, Department of Microbiology & Infection Control, Statens Serum Institut Copenhagen, Denmark.
Jean-Jacques ParientiUnité de Biostatistiques et de Recherche Clinique, CHU Caen Caen, France.
Pierre TattevinService de Maladies Infectieuses, CHU Rennes Rennes, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bloodstream infection (BSI) is a major cause of death in developed countries and the detection of microorganisms is essential in managing patients. Despite major progress has been made to improve identification of microorganisms, blood culture (BC) remains the gold standard and the first line tool for detecting BSIs. Consensus guidelines are available to ensure optimal BSI procedures, but BC practices often deviate from the recommendations. This review provides an update on clinical and technical issues related to blood collection and to BC performance, with a special focus on the blood sample strategy to optimize the sensitivity and specificity of BCs.

Indexed as

blood culturebloodstream infectioncontaminationmulti-sampling strategysensitivitysingle sampling strategyspecificity

Identifiers

PMID27242721
PMCPMC4863885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.